252 related articles for article (PubMed ID: 6263471)
1. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
[No Abstract] [Full Text] [Related]
2. [Comparative study of 2 different chemotherapeutic combinations in epidermoid carcinoma of the lung. Preliminary results].
Pipino G; Germiniani R; Maione G; Fazio FM
Arch Sci Med (Torino); 1983; 140(2):135-8. PubMed ID: 6192792
[No Abstract] [Full Text] [Related]
3. [Evaluation of the effectiveness of 2-drug and multi-drug chemotherapy in primary lung cancer].
Durda M; Skublewski A; Patyra R; Ziemecka E
Pneumonol Pol; 1979; 47(7-8):603-7. PubMed ID: 231773
[No Abstract] [Full Text] [Related]
4. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
[No Abstract] [Full Text] [Related]
5. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
Livingston RB; Mira J; O'Bryan RM
Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
[No Abstract] [Full Text] [Related]
6. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
[TBL] [Abstract][Full Text] [Related]
7. Intensive induction therapy for small cell carcinoma of the lung.
Abeloff MD; Ettinger DS; Khouri NF; Lenhard RE
Cancer Treat Rep; 1979 Apr; 63(4):519-24. PubMed ID: 221117
[TBL] [Abstract][Full Text] [Related]
8. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
Miller CF; Weltz MD; Heim WJ; Blom J
Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
[No Abstract] [Full Text] [Related]
9. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
10. Combined modality treatment of small cell carcinoma of the lung.
Feld R; Pringle JF; Evans WK; Keen CW; Quirt IC; Curtis JE; Baker MA; Yeoh JL; Deboer G; Brown TC
Arch Intern Med; 1981 Mar; 141(4):469-73. PubMed ID: 6260048
[TBL] [Abstract][Full Text] [Related]
11. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
[TBL] [Abstract][Full Text] [Related]
12. [A study of two protocols of multiple chemotherapy in small round cell tumours of the lung (author's transl)].
Israël L; Breau JL; Depierre A; Choffel C; Lemarié E; Battesti JP
Rev Fr Mal Respir; 1981; 9(2):123-31. PubMed ID: 6166970
[No Abstract] [Full Text] [Related]
13. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
14. [Polychemotherapy of small-cell lung cancer].
Krawczyk K; Krochmal M; Pawlicki M; Kulpa J
Pneumonol Pol; 1983 Feb; 51(2):101-5. PubMed ID: 6308583
[No Abstract] [Full Text] [Related]
15. Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.
Davis S; Pandya MR; Rambotti P
Cancer Treat Rep; 1980; 64(4-5):685-8. PubMed ID: 6253067
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
17. Results of a phase II protocol for evaluation of new chemotherapeutic regimens in patients with inoperable non-small cell lung carcinoma (EST-2575, generation I).
Creech RH; Mehta CR; Cohen M; Donavan M; Sponzo R; Mason BA; Skeel RT; Ahmed F; Creaven PJ; Lerner HJ; Foelsch E
Cancer Treat Rep; 1981; 65(5-6):431-8. PubMed ID: 6263476
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
[TBL] [Abstract][Full Text] [Related]
19. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide].
Krawczyk K; Krochmal M; Pawlicki M; Kulpa J; Zielezińska A
Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054
[No Abstract] [Full Text] [Related]
20. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]